- Home
- / Zhongzhi Pharmaceutical Holdings
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Zhongzhi Pharmaceutical Holdings financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.9
2024-10-29
Market Capitalization
$769.2 M
2024-10-29
Revenue
¥1.7 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.1B | 1.3B | 1.6B | 1.7B | 1.8B | 2.0B | 2.2B | 1.7B |
| Cost of goods sold | 409.6M | 445.8M | 515.8M | 603.3M | 660.9M | 733.0M | 818.4M | 651.2M |
| Gross profit | 742.9M | 896.8M | 1.1B | 1.2B | 1.2B | 1.3B | 1.4B | 1.1B |
| Gross profit margin, % | 65.0% | 66.8% | 67.9% | 66.6% | 64.2% | 65.1% | 63.8% | 63.3% |
| Operating expense total | 627.4M | 694.9M | 846.9M | 978.1M | 965.3M | 1.1B | 1.2B | 987.2M |
| Depreciation and amortization | 25.5M | 63.5M | 99.7M | 85.1M | 96.4M | 102.1M | 111.4M | 102.5M |
| EBITDA | 115.5M | 201.9M | 241.6M | 185.7M | 207.8M | 284.3M | 254.2M | 112.6M |
| EBITDA margin, % | 10.1% | 15.0% | 15.1% | 10.6% | 11.4% | 13.9% | 11.5% | 6.5% |
| EBIT | 88.2M | 142.9M | 154.6M | 104.3M | 130.6M | 205.0M | 158.4M | 17.6M |
| EBIT margin, % | 7.7% | 10.6% | 9.6% | 6.0% | 7.2% | 10.0% | 7.2% | 1.0% |
| Interest income | 9.0M | 8.2M | 10.0M | 4.2M | 3.8M | 7.0M | 5.1M | 3.0M |
| Interest expense | 239.0K | 4.0M | 5.2M | 7.1M | 6.6M | 7.9M | 7.0M | 5.4M |
| Pre tax profit | 101.8M | 155.9M | 167.2M | 61.8M | 130.7M | 207.6M | 146.9M | 19.0M |
| Income tax expense | 16.8M | 41.2M | 28.6M | 9.4M | 23.7M | 43.4M | 50.8M | 1.3M |
| Net Income | 85.1M | 114.7M | 138.6M | 52.4M | 106.9M | 164.1M | 96.1M | 17.7M |